Company / Gross Margin
LIFECORE BIOMEDICAL, INC. \DE\ Gross Margin History
FY2012-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
15.1%
FY2019
5-year range
2.6% / 15.1%
FY2015-FY2019
Trend
+7.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from 2.6% to 15.1% over the past 2 years.
Based on SEC 10-K filings.
15.1% in FY2019 with a 5-year CAGR of -1.3%.
Improved from 2.6% to 15.1% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +2.0pp
- 5-Year Change
- -1.3pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2019, gross margin increased 7.9% year-over-year.
- Peak gross margin was recorded in FY2013.
- Lowest gross margin in the period was in FY2017.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | 15.1% | +7.9% |
| FY2018 | 14.0% | +432.3% |
| FY2017 | 2.6% | -80.0% |
| FY2016 | 13.1% | -7.7% |
| FY2015 | 14.2% | -13.5% |
| FY2014 | 16.4% | -2.7% |
| FY2013 | 16.9% | +19.1% |
| FY2012 | 14.2% | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026